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Introduction
In 3 to 5 percent of patients afflicted with multiple sclerosis (MS) symptoms start during childhood or adolescence [1, 2] . The inflammatory and neurodegenerative impact of MS meets the brain during a critical time period and may disturb ongoing myelination and other cerebral maturation processes [3] . Whereas permanent physical handicaps are usually rare and mild in paediatric MS (paedMS) patients [4, 5] , approximately one third of children and adolescents experience cognitive decline early after onset of disease [6] .
Comprehensive reviews have been published recently, summarizing the available studies on cognitive deficits in paedMS patients [7] [8] [9] [10] . Similar to adult-onset cases of MS, attention and information processing are frequently impaired [11] [12] [13] . Particularly the Symbol Digit Modalities Test (SDMT), an established screening test in adults with MS assessing information processing speed, has been proposed as cognitive screen also in paedMS [14] . Several studies report on deficits in spatial and verbal memory tasks in paedMS patients, including working memory, short-and long-term capacities with variable extent [11, 12, 15, 16] . Impaired language skills are also often noticed in paedMS and may involve receptive and expressive language, particularly detected with complex and speed-dependent linguistic tasks [11] [12] [13] . The extent of linguistic impairment appears to be the main neuropsychological difference between children and adults with MS. Language dysfunction is relatively rare for adult patients.
The detection of potential deficits in executive functions and fluid reasoning has not been at the centre of interest of most published studies on cognitive impairment in paedMS. However, cognitive processes such as attentional control, working memory, inhibitory control, flexibility, problem solving and reasoning are important requirements for the achievement of milestones in adolescence including successful school performance, emancipation from the parental home and development towards self-dependence. Therefore, assessing deficits in executive functions and fluid reasoning is of particular interest for paedMS patients. A study by Till and colleagues [17] explicitly focussed on detecting deficits in executive functions in a group of 34 adolescents with paedMS. They found that 44% of patients were impaired in the Trail Making Test (TMT) Part B, which assesses cognitive flexibility, multitasking and simultaneous processing. The TMT Part B is the most frequently applied test in studies assessing executive functions in paedMS. Results are inconsistent, however, with some studies reporting deficits [11, 12, 15, 18] while others do not [19, 20] . Further tests of executive functions, which have occasionally been applied, are the Tower of London Test [19, 21] , the Wisconsin Card Sorting Test [13, 17] or its short version [11, 12] and tests resembling the stroop task [16, 17] all with largely inconspicuous results. However, previous studies have found that paedMS patients seem to be particularly vulnerable for deficits in calculation skills [11, 22] .
The goal of the present study was to assess the extent and domains of cognitive impairment with a focus on executive functions and fluid reasoning in a German paedMS patient cohort and relate outcomes to clinical disease parameters. Since the available studies in this field have been accomplished in countries with comparable sociodemographic, educational and medical resources, we expected a similar distribution of cognitive impairment in our MS patients as previously imported. Reciprocally, this would allow for an inference for our results regarding executive functions to other cohorts of paediatric MS patients, which have not been investigated accordingly before.
Materials and methods

Subjects
Forty German MS patients between 11 and 18 years of age were recruited at the German centre of MS in childhood and adolescence in Göttingen consecutively within a time period of two years, when they presented for their semi-annual check-up. Its catchment area covers all of Germany. All patients met diagnostic criteria of MS according to Krupp et al. [23] ; other neurological diseases had been excluded. Additional exclusion criteria were psychiatric diagnoses, severe psychological problems, learning difficulties, insufficient German proficiency and an IQ below 70. We did not include patients younger than 11 years because several of the psychological tests applied in our battery were not applicable to younger subjects. At the time of psychological and clinical evaluation all subjects were both relapse free and not on steroids for at least four weeks. Age and sex matched healthy controls were recruited via advertisements at local schools and in the hospital. Additional to the exclusion of all neurologic illnesses, exclusion criteria for controls were the same as for patients. Written informed consent was obtained from participants and their parents. The ethics committee of the University Medical Center Göttingen approved the study.
Clinical and neuropsychological assessment
Each patient was seen by a paediatric neurologist for an assessment of clinical history and treatment. A neurologic examination was performed including the Expanded Disability Status Scale (EDSS). A trained psychologist conducted a comprehensive neuropsychological test battery, which required two sessions on separate days, each lasting 90 to 120 minutes. For the detailed description of all tests and their cognitive domains see Table 1 .
Statistical analysis
All neuropsychological tests were analysed according to the manual. Whenever possible scaled scores were computed, which take age and gender into account. Otherwise, raw scores were used. Note that age and gender were still controlled for as patients and controls were matched accordingly. For each domain and neuropsychological test we tested for statistical differences between patients and controls using between-subjects ANOVAs. A significance level of 5% was adopted. We refrained from computing MANOVAs, because different tests subsumed under the same domain of cognitive functioning may tap into different aspects. As effect sizes we computed standardized mean differences (Cohen's d) [24] . Effects are considered small if d > = 0.2, medium if d > = 0.5, and large if d > = 0.8. A power analysis showed that effects of d > = 0.66 would result in a statistically significant finding with a power of 0.8 given our final sample size of N = 74. Thus, our sample was large enough to discover medium to large effects with high statistical power. In addition, we analysed whether clinical parameters of the patients predicted cognitive functioning. To do so, we classified patients according to age of onset (up to 14 years of age vs. older), disease duration (up to one year vs. more than one year), number of relapses (one vs. more than one), and EDSS score (0 and 1 vs. 2, 3, and 4). The specific cut-offs for the groups were chosen taking both clinical meaningfulness into account and the number of subjects in each group. This classification was introduced in order to avoid a bias of a classical correlation analysis by outliers. ANOVAs with clinical parameters as factors were computed for all test scores.
Results
We initially evaluated 40 German paedMS patients and 60 healthy controls. Of the patients, 37 received a disease modifying therapy: 26 interferon beta, 4 glatirameracetate, 4 natalizumab and 3 fingolimod. For each patient, we selected a sex-matched healthy control with the same Attention / alertness to visual detail, visual discrimination S views a picture and then points to or names the important part missing within a specified time limit
Abbreviations not explained in the age (+/-3 months) at the time of testing. If more than one healthy control equally matched a patient, we took the control subject which was recruited earlier into the study. From the initial sample, 37 patients and 37 age and sex matched controls were included into the final comparative analyses. Three patients had to be excluded because no healthy control was available. The level of secondary school education was equal for patients and controls in our sample. Regarding parental education, 25% of the fathers and 37.5% of the mothers of paedMS patients had a higher educational level (more than 9 years of school) compared to 43.5% of the fathers and 52.2% of the mothers of the healthy controls. For a detailed description of the study sample and clinical parameters of the patients see Table 2 .
The results of paedMS patients and matched healthy controls are shown in Table 3 . P-Values of statistical comparisons between groups and effect sizes (Cohen's d) are also provided. First we analysed the overall IQ and indices provided by the Wechsler Intelligence Scales for Children (WISC) and Adults (WAIS). According to their age, 38 subjects were assessed with the WAIS and 36 subjects using the WISC. We assigned each WISC/WAIS subtest and all other individual tests to one of five predefined cognitive domains 1) verbal comprehension and fluency, 2) processing speed, 3) memory excluding working memory, 4) working memory and executive functions and 5) fluid reasoning in order to gain a better insight into domainspecific differences between patients and controls. Assignments were based on the primary cognitive domain targeted by each test as described in Table 1 .
In the following, for readability, we report mean test scores in brackets for patient (Pat) and Controls (Con) as well as the P-value (p). For standard deviation and effect size please see Table 3 . With respect to global measures of intelligence we found that the average overall IQ was lower in paedMS patients (Pat 97.1, Con 108.9, p = 0.003). They also had significantly lower scores in verbal comprehension (Pat 95.9, Con 107.5, p = 0.001) and processing speed (Pat 98.5, Con 106.5, p = 0.017).
With regard to verbal comprehension and fluency, WISC subtests (CO: Pat 8.5, Con 11.2, p = 0.000; VC: Pat 9.5, Con 11.7, p = 0.003; IN: Pat 8.8, Con 10.8, p = 0.005; SI: Pat 9.8, Con 11.1, p = 0.017) showed a clear impairment of patients compared to controls with medium to large effect sizes. These tests assess verbal concept formation and reasoning, general knowledge, knowledge of social conventions and general information acquired from culture. Semantic and phonemic verbal fluency, verbal flexibility and word finding were not afflicted in our sample of paedMS patients (RWT, K-NEK).
Concerning processing speed, the SDMT, the WISC CD and the d2-R yielded a significantly lower performance in patients (SDMT written: Pat 50. of subtests from the WISC (SS and CA), which are part of the processing speed index, were not different between the groups. The SDMT written and WISC CD were the tests with the highest effect size in this domain. Both test have a very similar task structure. In the domain of memory excluding working memory, verbal short-and long-term memory were impaired in paedMS patients (VLMT training: Pat 56.5, Con 62.3, p = 0.007; VLMT delay: Pat 53.0, Con 58.5, p = 0.011). Visual-spatial short-term memory was negatively affected in a demanding task (MLT PL training: Pat 49.7, Con 55.7, p = 0.009) but this was not so clean in an easier task (MLT SP: Pat 48.6, Con 54.0, p = 0.077). Visual spatial long-term memory was not significantly affected (MLT PL delay: Pat 52.7, Con 55.2, p = 0.299). Thus, paedMS patients scored inferior to controls in both visual spatial and verbal memory tasks, but the difference was more pronounced for the latter.
Working memory was impaired in patients as well, although not all tests assessing this function yielded significant group differences. Only the more difficult tests such as the CBTT backward task and the WISC LN showed group-differences with moderate effect sizes (CBTT bw: Pat 57.1, Con 70.6, p = 0.003; WISC LN: Pat 10.3, Con 11.5, p = 0.030). Regarding other executive functions, significant differences between the groups were found in the WISC AR (Pat 9.2, Con 11.0, p = 0.002), assessing calculation skills, and the D-KEFS DF (Pat 9.7, Con 11.5, p = 0.003), which requires problem solving skills, non-verbal creativity, fluency in generating visual patterns, cognitive shifting and inhibition. Other classical tests of executive functions such as the D-KEFS TMT and CWI did not yield any group differences. Motor speed and visual scanning assessed by subconditions of the D-KEFS TMT were not affected in paedMS patients (see S1 Table for results of all D-KEFS DF, TMT and CWI subconditions). Fluid reasoning was largely intact in paedMS patients. A significantly worse performance in patients was only observed in the WISC MR (Pat 10.4, Con 11.7, p = 0.031). Fig 1 graphically depicts the effect size of all tests applied in our study arranged by cognitive domain. The figure shows that in each cognitive domain except for fluid reasoning small to medium effects were found. Measures with a large effect size were the WISC CO, the SDMT written and WISC verbal comprehension index.
We then analysed whether clinical parameters of paedMS patients were related to cognitive test scores. This analysis is based on all forty patients initially assessed. As explained above, paedMS patients were classified into clinically meaningful groups for age of disease onset, disease duration, number of relapses, and EDSS Score. Findings that were significant or approached significance (p<0.10) are reported in Table 4 . Age at disease onset had a significant influence on fluid reasoning (WISC MR: p = 0.024). Interestingly, patients with disease onset at an earlier age showed a consistently better test performance than patients with disease onset at a higher age. As expected, the disease duration negatively affected test performance in several domains (verbal comprehension and fluency: WISC VC: P = 0.034, WISC IN: In order to determine whether the better cognitive performance of patients with an earlier disease onset was due to a shorter disease duration, we also compared the disease duration in the two groups. But contrariwise it turned out that patients with a disease onset at the age of 11-14 years actually had a significantly longer disease duration than patients with disease onset above 14 years (Pat 11-14: 31.8 months, SD 21.0; Pat > 14: 14.9 months (SD 7.6); p = 0.001).
Last, we explored whether there were differences in cognitive impairment between patients receiving basic therapy (interferon beta, glatirameracetate) or no therapy (N = 33 in total) and patients receiving escalation therapy (natalizumab, fingolimod; N = 7). For results see Supplementary Table 1. Although mean values tended to be lower in the escalation therapy group, statistically significant group differences were only observed for few scores (WISC VC: p = 0.013; WISC AR: p = 0.024; verbal comprehension index: p = 0.032). This lack of significant differences is not surprising given the unequal group sizes.
Discussion
This is the first study assessing cognitive impairment in paedMS patients in the Germanspeaking countries. We applied a very comprehensive test battery with individual tests chosen based on previously published recommendations for cognitive assessments in MS patients and with a focus on the assessment of executive functions and fluid reasoning. Our results confirm and extend previous findings on cognitive impairment in paedMS patients [7] [8] [9] [10] . In the study, we matched each paedMS patient with an age and gender equivalent healthy control. This enabled us to conduct statistical analyses controlling for age and gender even when there were no standard values for a test available. We refrained from introducing a classification of cognitive impairment based on z-scores. Instead, we report significant group differences as important indicator for deficits in paedMS patients. In our sample, we found a reduced performance of paedMS patients in tests assessing verbal comprehension and fluency, processing speed, memory excluding working memory, working memory and executive functions and fluid reasoning. However, there were important differences concerning the extent of impairment in the different cognitive domains, shown by the number of tests with statistically significant differences between patients and controls in each domain as well as the variable effect size of the individual tests.
A particular focus of our study were deficits in executive functions and fluid reasoning in paedMS patients, since previous studies have only marginally touched this issue. Therefore, we conducted several subtests of the Delis-Kaplan Executive Function System (D-KEFS), which comprises a number of well-designed tests covering key components of verbal and spatial executive function modalities. To our surprise, results showed only deficits in problem solving, nonverbal creativity and cognitive shifting skills (as assessed by the D-KEFS-DF). To our knowledge no other study has ever used the D-KEFS DF in paedMS patients. Several previous studies report an impairment of paedMS patients in simultaneous processing and divided attention (TMT Part B) [30] [31] [32] but others show inconsistent results similar to our findings [12, 33] . One other study assessed spatial planning and rule learning (D-KEFS TT) [12] , respectively verbal inhibition and cognitive flexibility (D-KEFS CWI) [32] , each without finding group differences in accordance with our results. We also found deficits of paedMS patients in working memory and calculation skills (as assessed by the WISC AR). This is in line with previous studies, which found that paedMS patients are especially vulnerable to calculation deficits [11, 22] . Based on our findings in the executive function domain, we suggest to use the D-KEFS-DF for future patient assessments of executive function deficits. In contrast to "classical" tests as the stroop task or the Tower of London applied in previous studies the D-KEFS-DF proofed to be more reliable to reveal potential impairments in executive functions.
Working memory, also an executive function, was impaired in paedMS patients but only the more cognitively demanding tests assessing this function (CBTT backward task, WISC LN) yielded significant group differences. This may indicate that basic working memory capabilities remain preserved in paedMS patients (see WISC DS). However, the US study group also applied with WISC DS in their test battery and found a reduced test performance in paedMS patients [16] . Still, more demanding tests may be better suited to assess potential working memory deficits.
We found important group differences in the domain verbal comprehension and fluency, with a clear impairment of paedMS patients compared to controls. PaedMS patients had less deficits in verbal fluency than in verbal comprehension. Pronounced language deficits and deterioration over time have been reported in longitudinal observation study in Italy, with verbal fluency being initially less affected [12, 19, 21] . A large Canadian study also reported important language deficits [13] . However, in a US cohort, language deficits were less pronounced [16] . Our results are closer to the findings in the European and Canadian study groups. Reviewing the available information on language skills in MS patients, we found that our test selection omitted or only marginally touched several aspects such as receptive, expressive and productive language skills. For a sound evaluation of the extent of deficits in language skills in paedMS patients, additional studies are necessary with a focus on this aspect.
Note that several tests in the language domain also require executive function skills (e.g. WISC CO, VC and SI). The high impairment rates of paedMS patients in these tests indicate that executive functions in language may be impaired in patients, which may have an important impact on school performance and communication skills.
Processing speed was also very affected in paedMS patients. This is a frequent finding in studies assessing cognitive impairment in paedMS patients. Deficits were most pronounced in tests that required a translation of numbers into geometric shapes according to a given key (SDMT and WISC CD). Apparently, this type of test is ideally suited to assess processing speed deficits in paedMS patients and is superior to differently designed tests. Our findings also support the recommendation that the SDMT should be used as a screening test for cognitive deficits in MS [14] . Interestingly, the written SDMT yielded a higher effect size than its oral version, probably because it additionally requires visuomotoric skills.
PaedMS patients scored inferior to controls in memory tasks and group differences were larger for verbal memory compared to visual spatial tasks. Possibly, the verbal memory performance was influenced by the frequent impairment of paedMS patients in verbal comprehension. However, in a Canadian study, verbal memory was largely intact although patients had impaired verbal comprehension and fluency [13] . The Italian study group reported a frequent and equal distribution of verbal and spatial memory impairment in paedMS patients [12, 19, 21] . The US network focussed on the assessment of verbal learning and found important deficits in this domain [16] . Thus, memory is consistently impaired in paedMS patients but the deficits regarding verbal and spatial aspects may differ depending on the study population and the administered tests.
Clinical disease parameters turned out to be only modestly associated with some aspects of cognitive performance. The findings give some support to the hypothesis that a longer disease duration goes along with a higher extent of cognitive impairment. No significant relations were found regarding EDSS and the number of relapses. Interestingly, disease onset turned out to be important. PaedMS patients diagnosed at age 14 or younger had better cognitive scores in several domains than patients being diagnosed later. This statistical relation was not biased by disease duration, in fact, patients with a younger disease onset had a longer disease duration than patients with a later disease onset. Our finding is in contrast to a previous study which reports that younger age at disease onset is a positive predictor of cognitive impairment [12] . However, Suppeij and Cainelli reanalysed the data and found that associations of more severe cognitive dysfunction with earlier disease onset largely disappeared after controlling for disease duration [8] . Our own personal experience from daily clinical practise supports the assumption that young patients may be better able to compensate for cognitive impairment, possibly due to the ongoing maturation processes in the central nervous system, which facilitates brain plasticity and restructuring [35] .
A limitation of the study is the sample size. Our sample size provided sufficient statistical power to detect moderate to large effects. Nevertheless, to ensure that even small effects will be identified with statistically significant differences more patients and controls are needed. A second potential limitation is that the healthy controls had above average IQ values. Most comparable studies assessing cognitive deficits in paedMS [11] [12] [13] have the same issue. We matched patients and controls for the statistical analyses according to gender and age and deliberately decided against including IQ because IQ is likely to be affected by MS and is one feature of cognitive decline. The level of secondary school education was equal for patients and controls in our sample even though the parental education was higher in the control group. We assume that the lower IQ in our paedMS patients is an indicator for their cognitive impairment. However, higher baseline abilities in the control group due to a selection bias cannot be excluded.
Conclusion
In conclusion, this study confirms the high prevalence of cognitive deficits in paedMS patients with reduced performance particularly in tasks assessing processing speed, verbal comprehension, memory and executive functions. Our results are largely comparable to previous European and North American studies in paedMS patients. Our thorough assessment of executive functions shows that impairments occur in paedMS patients, in particular with respect to design fluency, working memory, calculation skills and verbal concept formation. A longer disease duration and later disease onset go along with more severe cognitive deficits. The frequent impairment of verbal comprehension and calculation skills imposes an important risk factor for deterioration of school performance. In addition to the widely applied cognitive tests, we encourage a systematic inclusion of the D-KEFS DF and the WISC AR for the evaluation of executive functions including calculation skills. Finally, the results imply that all paedMS patients should have access to a comprehensive cognitive screening including verbal and mathematical skills in order to soon provide specific support or disability compensation where this is necessary. Further studies are necessary to give a sound insight into the extent of impairment of receptive and expressive language skills in paedMS patients. 
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